Jorge Garcia Young, MD
Radiation Oncology · Modesto, CANPI 1902860802
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,478 of the $8,848 with a category attached, or 84.5%. It is spread thinly across 35 manufacturers, the largest accounting for just 10.7% — the pattern of someone who eats at a lot of different presentations. Among radiation oncology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 83 payments — averaging $106.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$945
- AstraZeneca$900
- Johnson & Johnson$621
- Amgen$519
- Gilead$503
- Bioprotect Medical, Inc.$492
- plus $5K from 29 others
Across 2 payments — averaging $1464.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$3K
What the payments were for
- Travel & lodging$1,37015%
- Food & beverage$7,47885%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 5 | $945 |
| AstraZeneca | 8 | $900 |
| Johnson & Johnson | 6 | $621 |
| Amgen | 5 | $519 |
| Gilead(2 entities) | 5 | $503 |
| Bioprotect Medical, Inc. | 3 | $492 |
| E.r. Squibb & Sons, L.L.C. | 5 | $478 |
| Genentech USA, Inc. | 4 | $446 |
| Seagen Inc. | 4 | $382 |
| Siemens Medical Solutions USA, Inc. | 4 | $336 |
| GT Medical Technologies, Inc | 3 | $320 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $236 |
| Merck | 2 | $215 |
| Eisai Inc. | 2 | $213 |
| Lilly USA, LLC | 2 | $187 |
| Pfizer | 2 | $181 |
| Novocure Inc. | 1 | $148 |
| Astellas Pharma US Inc | 1 | $125 |
| Incyte Corporation | 1 | $125 |
| GSK | 1 | $125 |
| Sobi, Inc | 1 | $121 |
| Shoulder Innovations, Inc. | 1 | $115 |
| Daiichi Sankyo Inc. | 1 | $111 |
| Stemline Therapeutics Inc. | 1 | $111 |
| Novartis | 1 | $106 |
| Tesaro, Inc. | 1 | $105 |
| AbbVie | 2 | $102 |
| Rigel Pharmaceuticals, Inc. | 1 | $101 |
| Brainlab, Inc. | 1 | $100 |
| ADC Therapeutics America, Inc. | 1 | $100 |
| Regeneron Healthcare Solutions, Inc. | 1 | $98 |
| Focal Therapeutics, Inc. | 1 | $72 |
| Advanced Accelerator Applications | 1 | $57 |
| Teleflex LLC | 2 | $41 |
| Tactile Systems Technology Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,848 in reported general payments places this provider in the 90th percentile of 627 radiation oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 95 | $1,344 |
| Dexamethasone | 21 | $411 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $91 |
| Ciprofloxacin Hcl | 11 | $40 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Modesto
- Rakesh PatelLos Gatos$1.3M
- Amir LavafPalm Springs$411K
- Albert ChangLos Angeles$290K
- Arya AminiDuarte$265K
- Rizwan NuraniApple Valley$220K
- Drew MoghanakiLos Angeles$183K
- Jyoti MayadevSan Diego$170K
- Percy LeeIrvine$125K
- Felix FengSan Francisco$99K
- Hyun KimDuarte$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.